XASXTGH
Market cap11mUSD
Jan 06, Last price
0.04AUD
1D
0.00%
1Q
-4.88%
IPO
-80.00%
Name
Terragen Holdings Ltd
Chart & Performance
P/E
—
P/S
8.83
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
13.07%
Rev. gr., 5y
16.85%
Revenues
2m
-34.76%
Net income
-3m
L-6.80%
CFO
-2m
L-17.36%
Earnings
Feb 18, 2025
Profile
Terragen Holdings Limited engages in the research, development, production, and sale of biological products for agriculture sector in Australia and New Zealand. It offers Mylo, an animal feed supplement; and Great Land, a liquid biological soil conditioner that improves soil characteristics. The company was incorporated in 1996 and is based in Coolum Beach, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||
Revenues | 2,137 -34.76% | 3,276 13.32% | 2,891 -20.85% | |||||
Cost of revenue | 5,449 | 4,367 | 6,382 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | (3,311) | (1,091) | (3,491) | |||||
NOPBT Margin | ||||||||
Operating Taxes | (869) | (742) | (893) | |||||
Tax Rate | ||||||||
NOPAT | (2,442) | (350) | (2,598) | |||||
Net income | (3,014) -6.80% | (3,234) -40.19% | (5,407) -11.36% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 3,503 | 619 | 142 | |||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 318 | 219 | 176 | |||||
Long-term debt | 619 | 127 | 488 | |||||
Deferred revenue | ||||||||
Other long-term liabilities | 32 | 46 | 45 | |||||
Net debt | (3,606) | (3,828) | (6,005) | |||||
| Cash flow | ||||||||
Cash from operating activities | (2,321) | (2,809) | (4,798) | |||||
CAPEX | (24) | (103) | (176) | |||||
Cash from investing activities | (133) | (35) | (118) | |||||
Cash from financing activities | 2,823 | 351 | (53) | |||||
FCF | (3,073) | 131 | (2,296) | |||||
| Balance | ||||||||
Cash | 4,543 | 4,174 | 6,669 | |||||
Long term investments | ||||||||
Excess cash | 4,436 | 4,010 | 6,525 | |||||
Stockholders' equity | 5,316 | 5,076 | 7,761 | |||||
Invested Capital | 1,455 | 1,351 | 1,613 | |||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 345,240 | 195,149 | 192,940 | |||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | (2,955) | (598) | (2,882) | |||||
EV/EBITDA | ||||||||
Interest | 29 | 10 | 6 | |||||
Interest/NOPBT | ||||||||